Search Count: 60
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166A With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant L50F E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: DMS, V2M, CL |
 |
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUY |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUX |
 |
Co-Structure Of Main Protease Of Sars-Cov-2 (Covid-19) With Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-10-16 Classification: HYDROLASE Ligands: A1AU4 |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L141R With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: DMS, V2M, NA |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant N142P With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L50F With Nirmatrelvir Captured In Two Conformational States
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: DMS, 4WI, NA, CL |
 |
Co-Structure Of Sars-Cov-2 (Covid-19 With Covalent Pyrazoline Based Inhibitors)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-06-07 Classification: HYDROLASE, Viral Protein/Inhibitor Ligands: I3R, IMD |
 |
Co-Structure Of Sars-Cov-2 (Covid-19 With Covalent Pyrazoline Based Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2023-06-07 Classification: HYDROLASE Ligands: A1W |
 |
Crystal Structure Of Sars Cov-2 Mpro With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN/HYDROLASE/INHIBITOR Ligands: GOL, V2M, DMS |
 |
Crystal Structure Of Porcine Deltacoronavirus (Hku-15) Mpro With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Porcine deltacoronavirus
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M, GOL, DMS |
 |
Crystal Structure Of Beluga Whale Gammacoronavirus Sw1 Mpro With Gc-376 Captured In Two Conformational States
Organism: Beluga whale coronavirus sw1
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN Ligands: K36, B1S, GOL |
 |
Organism: Beluga whale coronavirus sw1
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN Ligands: SO4, PEG |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp4/5 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp5/6 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp6/7 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp7/8 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp8/9 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |